Related Experiment Video
Updated: Jun 4, 2026

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
Published on: September 19, 2025
The Future of Cancer Survivorship Care for Veterans
Jennifer Moye1, Jennifer L Schuster, David M Latini
1Dr. Moye is a staff psychologist at the VA Boston Healthcare System (VABHS) and an associate professor of psychology in the department of psychiatry at Harvard Medical School, both in Boston, MA. Dr. Schuster is the project coordinator for the National Center for Posttraumatic Stress Disorders, Women's Health Sciences Division at VABHS. Dr. Latini is a research health scientist and Dr. Naik is an attending physician in the medical care and the geriatrics and extended care lines, both at the Michael E. DeBakey VA Medical Center, Houston, TX. In addition, Dr. Latini is an assistant professor of urology and Dr. Naik is an assistant professor of medicine in the sections of health services research and geriatrics medicine, both at Baylor College of Medicine, Houston, TX.
Abstract:
Veterans have unique risk factors for cancer and comorbidities that may complicate cancer survivorship care. These population-specific characteristics compel research into the needs of veteran cancer survivors to inform best practice.
Related Concept Videos
Cancer Survival Analysis
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers
Treatment Resistent Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...